Arrowhead Pharmaceuticals market cap
As of November 2026, Arrowhead Pharmaceuticals (ARWR) has a market capitalization of $6.09 B, which makes it #1179 among the world’s largest public companies. Over the past year its value changed by −17.2%.
Market cap$6.09 B
World rank#1179
1 year−17.2%
Share price$43.65
Market cap over time
By year
| Year | Value | Change |
|---|---|---|
| 2026 | $6.09 B | −34.3% |
| 2025 | $9.27 B | +253% |
| 2024 | $2.62 B | −38.6% |
| 2023 | $4.27 B | −24.6% |
| 2022 | $5.66 B | −38.8% |
| 2021 | $9.26 B | −13.6% |
| 2020 | $10.71 B | +21.0% |
| 2019 | $8.86 B | +411% |
| 2018 | $1.73 B | +238% |
| 2017 | $513.80 M | +137% |
| 2016 | $216.41 M | −74.8% |
| 2015 | $858.66 M | −16.7% |
Market cap history is an estimate: monthly closing price × today’s share count, in US dollars at today’s exchange rate. Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.